Literature DB >> 6950464

Different responsiveness of a variety of isolated dog arteries to prostaglandin D2.

N Toda.   

Abstract

The addition of prostaglandin (PG) D2 contracted helical strips of dog cerebral, coronary, renal and femoral arteries; the contraction was greatest in cerebral arteries. The contractile response of cerebral arteries was potentiated by aspirin and attenuated by polyphloretin phosphate. In the arterial strips contracted with PGF2 alpha, PGD2 elicited a concentration-related relaxation; the relaxation was greatest in mesenteric arteries. In mesenteric arterial strips contracted with norepinephrine, a lesser degree of relaxation was induced, and in the K+-contracted arteries, only a contraction was induced. Treatment with PGD2 attenuated the contractile response of cerebral and mesenteric arteries to PGF2 alpha or PGE2; this inhibitory effect was approximately 10 times greater in mesenteric arteries. However, the response to serotonin (for cerebral arteries) or norepinephrine (for mesenteric) was unaffected. It may be concluded that the heterogeneity of responses to PGD2 of a variety of dog arteries is due to different contributions of vasoconstrictor and vasodilator mechanisms. PGD2 appears to share the mechanism underlying arterial contraction with PGF2 alpha and PGE2, and interferes with the effect of these PG's possibly on receptor sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6950464     DOI: 10.1016/0090-6980(82)90026-0

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

1.  Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries.

Authors:  T Okamura; M Nakajima; N Toda
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

2.  Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.

Authors:  N Toda
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

3.  Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.

Authors:  S Narumiya; N Toda
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.